Dr Paul Brennan
MRC bodies you are a member of:
- Development Pathway Funding Scheme panel
Main form of employment:
- University of Oxford, Nuffield Department of Clinical Medicine and Structural Genomics Constortium, principal investigator.
Research group/department web page/s:
Personal remuneration:
- Salary from the University of Oxford
Shareholdings and financial interests in companies
- None
Research income during current session [over £50k per grant]
- Wellcome Trust Grant (July 2011 – June 2015)
- Wellcome Trust Grant (January 2009– December 2012)
- The SGC receives funding from the following pharmaceutical companies: Abbott, GSK, Eli Lilly, Novartis, Pfizer and Takeda
Major academic collaborators [national and international]
- Chris Schofield, University of Oxford
- Stuart Conway, University of Oxford
- Darren Dixon, University of Oxford
Un-remunerated involvement with and membership of medical, bio-medical, pharmaceutical, healthcare provision or science or health policy/communication and similar activities/organisations
- Steering committee member of the 3D Fragments Consortium (EPSRC funded)
Political/pressure group associations:
- None
Family:
- None
